These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6294425)

  • 1. Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events.
    Garver DL; Johnson C; Kanter DR
    Life Sci; 1982 Nov; 31(18):1987-92. PubMed ID: 6294425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.
    Levine MA; Eil C; Downs RW; Spiegel AM
    J Clin Invest; 1983 Jul; 72(1):316-24. PubMed ID: 6308048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs.
    Kafka MS; van Kammen DP
    Arch Gen Psychiatry; 1983 Mar; 40(3):264-70. PubMed ID: 6131656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
    Tremblay J; Hamet P
    Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cyclic AMP production in the blood platelets from schizophrenic patients.
    Kafka MS; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 May; 136(5):685-7. PubMed ID: 219720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin receptor sensitivity in psychiatric disorders.
    Kanof PD; Johns C; Davidson M; Siever LJ; Coccaro EF; Davis KL
    Arch Gen Psychiatry; 1986 Oct; 43(10):987-93. PubMed ID: 3019269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
    Spence S; Houslay MD
    Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 action on adenylate cyclase activity and membrane lipids in platelets.
    Mruk J; Bakardjiev A; Burgermeister W
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):745-56. PubMed ID: 6957369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics.
    Rotrosen J; Miller AD; Mandio D; Traficante LJ; Gershon S
    Life Sci; 1978 Nov; 23(20):1989-96. PubMed ID: 214657
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormality of adenylate cyclase regulation in human platelet membranes in renal insufficiency.
    Jacobsson B; Ransnäs L; Nyberg G; Bergh CH; Magnusson Y; Hjalmarson A
    Eur J Clin Invest; 1985 Apr; 15(2):75-81. PubMed ID: 2986984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple effects of phorbol esters on hormone-sensitive adenylate cyclase activity in S49 lymphoma cells.
    Bell JD; Brunton LL
    Am J Physiol; 1987 Jun; 252(6 Pt 1):E783-9. PubMed ID: 3035937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.